Hodgkin Lymphoma: Leah’s Story - Johns Hopkins Medicine
Hodgkin Lymphoma: Leah’s Story Johns Hopkins Medicine
Hodgkin Lymphoma News
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV - The American Journal of Managed Care
Lymphoma Outcomes Hinge on Oncology, Not Viral Load In People With HIV The American Journal of Managed Care
UC Cancer Center, Hodgkin's International host event for cancer survivors - WKRC
UC Cancer Center, Hodgkin's International host event for cancer survivors WKRC
Maesteg teen whose cancer returned after remission has clinical trial hope - BBC
Maesteg teen whose cancer returned after remission has clinical trial hope BBC
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission - Pfizer
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission Pfizer
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia - Nature
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia Nature
Post-Treatment Fertility in Hodgkin Lymphoma - Hematology Advisor
Post-Treatment Fertility in Hodgkin Lymphoma Hematology Advisor
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up - Wiley Online Library
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up Wiley Online Library
Understanding Hodgkin lymphoma cell origins could yield better diagnostics - Cornell Chronicle
Understanding Hodgkin lymphoma cell origins could yield better diagnostics Cornell Chronicle
Simple Blood Test Ratio Predicts Survival in Hodgkin Lymphoma Patients on Immunotherapy - Bioengineer.org
Simple Blood Test Ratio Predicts Survival in Hodgkin Lymphoma Patients on Immunotherapy Bioengineer.org
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds - The ASCO Post
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds The ASCO Post
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult - UT MD Anderson
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult UT MD Anderson
Clarkston twins beat Hodgkin’s lymphoma, head off to college - ClickOnDetroit | WDIV Local 4
Clarkston twins beat Hodgkin’s lymphoma, head off to college ClickOnDetroit | WDIV Local 4
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma - Clemson University Athletics
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma Clemson University Athletics
Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down - STAT
Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down STAT
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal - Nature
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal Nature
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin - Nature
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma - Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma Nature
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma - CancerNetwork
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma CancerNetwork
Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review - Frontiers
Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review Frontiers
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial - BioPharma Dive
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial BioPharma Dive
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Frontiers
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” Frontiers
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma - CancerNetwork
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma CancerNetwork
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma - CancerNetwork
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma CancerNetwork
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - Health.com
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference Health.com
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature
Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade - Oncodaily
Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade Oncodaily
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase - CancerNetwork
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase CancerNetwork
CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy - Cureus
CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy Cureus
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma - CancerNetwork
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma CancerNetwork
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies - Frontiers
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies Frontiers
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? - Clinical Trials Arena
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? Clinical Trials Arena
Clarkston twins beat Hodgkin’s lymphoma, head off to college - ClickOnDetroit | WDIV Local 4
Clarkston twins beat Hodgkin’s lymphoma, head off to college ClickOnDetroit | WDIV Local 4
FDA Approves Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma - OncLive
FDA Approves Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma OncLive
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - UT MD Anderson
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group - The Lancet
Haematopoietic cell transplantation for relapsed or refractory classical Hodgkin lymphoma: a retrospective, registry-based cohort study of 19 498 patients from the EBMT Lymphoma Working Group The Lancet
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life - UT MD Anderson
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life UT MD Anderson
Intermittent Hypothermia in Hodgkin’s Lymphoma: A Potential Indicator for Urgent Chemotherapy Initiation - Wiley Online Library
Intermittent Hypothermia in Hodgkin’s Lymphoma: A Potential Indicator for Urgent Chemotherapy Initiation Wiley Online Library